Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases
The U.S. Food and Drug Administration (FDA) this week approved cobimetinib (Cotellic®), a precision medicine treatment for adults with any of a family…
Patient Education Webcasts
Spotlight On Myeloproliferative Neoplasms (MPNs)
_dam_file_150001.png?crop=true&keep=n&w=400&h=320)
News
FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration (FDA) has approved a new treatment, teclistamab (Tecvayli), for adults with multiple myeloma that has returned or con…
Patient Education Webcasts
Understanding My Treatment Options: Multiple Myeloma
News
Study from The Leukemia & Lymphoma Society Provides New Information on How Blood Cancer Patients Respond to COVID-19 Vaccines
A new study from The Leukemia & Lymphoma Society reports that blood cancer patients who do not produce detectable antibodies after COVID-19 vaccinatio…
News
22 Nonprofits Representing Patients Applaud ‘Family Glitch’ Fix as a Monumental Move to Expand Coverage
Millions of Americans will gain health insurance because of this rule
News
BURLINGTON STORES AND THE LEUKEMIA & LYMPHOMA SOCIETY CONTINUE THEIR PARTNERSHIP IN THE FIGHT AGAINST BLOOD CANCER
October 10, 2022 – Starting today through November 14, 2022, Burlington Stores is encouraging customers to donate at checkout in their more than 870 s…
News
The Leukemia & Lymphoma Society Financial Relief Fund Commits Over $1 Million in Direct Support to Blood Cancer Patients Impacted by Hurricanes Fiona & Ian
Rye Brook, NY – October 6, 2022 – In the wake of the destruction caused by Hurricane Fiona and Hurricane Ian, The Leukemia & Lymphoma Society (LLS) an…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
